Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $10.5200 (-4.54%) ($10.1800 - $11.1300) on Tue. Jun. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.2% (three month average) | RSI | 55 | Latest Price | $10.5200(-4.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(43%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -4.6% in a week (0% probabilities). VIXM(-31%) VXX(-27%) UNG(-10%) UUP(-8%) TLT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.6% (StdDev 9.2%) | Hourly BBV | 0 () | Intraday Trend | -4.6% | | | |
|
Resistance Level | $11.11 | 5 Day Moving Average | $11.08(-5.05%) | 10 Day Moving Average | $12.12(-13.2%) | 20 Day Moving Average | $11.11(-5.31%) | To recent high | -29.5% | To recent low | 84.9% | Market Cap | $782m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |